Skip to main content
Premium Trial:

Request an Annual Quote

TATAA Biocenter, UST Partner to Offer Long-Read Sequencing Services

NEW YORK – TATAA Biocenter of Gothenburg, Sweden, and Universal Sequencing Technology (UST) of Carlsbad, California, have partnered to develop and offer long-read sequencing application services using UST's TELL-Seq linked read technology, the firms said this week.

TELL-Seq (transposase enzyme-linked long-read sequencing) enables short-read second-generation sequencing platforms, like those from Illumina, to produce super long-range sequencing results, yielding average linked-read molecule lengths of greater than 40 kb and as high as 200 kb. The method only requires 3 to 5 ng of DNA input for the human genome and 0.1 to 0.5 ng for microbial genomes and targeted sequencing panels. Sequencing-ready libraries can be prepared in a PCR tube in about three hours using a simple workflow and basic lab equipment, TATAA said.

"TELL-Seq library technology is compatible with the range of Illumina sequencing platforms from benchtop like MiniSeq up to [the] high-throughput NovaSeq 6000," Aaron Levy, general manager and chief commercial officer at UST, said in a statement. "The collaboration between UST and TATAA, based on the growing need for long-read results with very accurate short-read Illumina sequencers, is speeding up the adoption of UST's super long-range TELL-Seq NGS library products among Illumina users in the US and all over the world."

The partners are currently running a pilot project using the method, and once that is completed, TATAA Biocenter will be offering it as a service, a TATAA Biocenter spokesperson said in an email.

The Scan

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.

Meta AI Computer Model Rapidly Predicts Hundreds of Millions of Metagenomic Proteins

Meta AI researchers describe in Science a new large language model that can predict the structures of millions of metagenomic proteins.

Hutch Team Develops Platform for Assessing Impact of SARS-CoV-2 Spike Mutations

The approach described in Cell relies on lentiviral pseudotyping for mutational scanning, which the researchers applied to the SARS-CoV-2 spike protein.

Potential New Therapeutic Target for Rheumatoid Arthritis Discovered

Researchers report in the American Journal of Human Genetics that SNPs implicated in rheumatoid arthritis often regulate the expression of the inflammation-related SPRED2 gene.